Chloe Flower

Chloe’s work spans the Engineering, Tech, Chemistry and Materials sectors, including oil and gas extraction, ceramic materials, corrosion protection, polymer processing, polymer films and adhesives, batteries, laundry technology, contact lenses, skin care, and medical devices.

Chloe has substantial experience in the prosecution and opposition/defence of patents relating to implantable medical devices and wound care, encompassing products such as orthopedic implants, bone grafts, bioactive glasses, hemostatic materials, wound closures and degradable/bioactive coatings. Chloe has successfully represented her clients at numerous EPO opposition and appeal proceedings, arguing convincingly and listening effectively, and is able to draw out points of weakness on the spot as well as reach logical and persuasive conclusions under pressure at hearings.

Chloe’s work also encompasses providing validity and infringement opinions and advising clients on freedom to operate. She has supported the firm’s dispute resolution team in UK litigation proceedings in cases regarding highly accurate long-read DNA sequencing technology (Pacific Biosciences of California v Oxford Nanopore, HP2017-000008 and HP2017-000025) and antimicrobial coated sutures (Ethicon v Meril, HP-2020-000041).

Chloe has valuable prosecution experience outside of Europe, in particular China, Korea, Japan and the US, working with attorneys worldwide to coordinate a global prosecution strategy. She enjoys getting to know her clients and takes great satisfaction from developing a deep understanding of their technologies, commercial goals and business needs, allowing her to take a value-driven and proactive approach to their patent strategy. Chloe’s clients, including Binx Health, Depuy Synthes, Enovix, Ethicon, Jubilant Draximage and Xeros, appreciate this focus and the tailoring of creative strategies across different jurisdictions according to their needs and requirements. She helps clients obtain robust protection for their inventions and provides a coordinated and strategic approach to manage their patent portfolios.

Chloe is an active member of the Chiefs in Intellectual Property (ChIPs) and Managing Intellectual Property (MIP) Women in IP Global Network groups, including speaking at the MIP Women in Leadership MIP Forum 2020. She was also involved in the Board of Appeal Key Decisions conference in 2019, taking part in the mock trial demonstrating the implementation of the new Rules of Procedure.

Chloe graduated from the University of Cambridge, where she was awarded a First Class in Natural Sciences (with the best performance in materials science) and completed a PhD in Biomaterials Science, researching biomaterials for heart tissue engineering. Her strong academic background means that she is well placed to advise on technical subject matter in the fields of industrial and consumer chemistry, renewable energy, medical devices and carbon-based materials.

Chloe is a talented flautist and keen swimmer and tries to find time to compete at National level alongside looking after her young family.